Global Energy Based Therapeutics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Energy Based Therapeutics Market Overview

The Energy Based Therapeutics Market was valued at USD 9.21 billion in 2025 and is projected to reach USD 17.95 billion by 2033, growing at a CAGR of 8.70% from 2026 to 2033. The Energy Based Therapeutics Market is experiencing consistent growth driven by rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and dermatological conditions, along with increasing demand for minimally invasive treatment options. Rapid advancements in medical energy-based technologies such as laser systems, radiofrequency (RF), ultrasound, microwave, and cryoablation are enhancing treatment precision, safety, and clinical outcomes across healthcare settings.

The increasing adoption of minimally invasive surgical procedures, combined with growing patient preference for faster recovery times and reduced hospital stays, is compelling hospitals, ambulatory surgical centers, and specialty clinics to adopt energy-based therapeutic systems. Laser-based and radiofrequency-based devices are increasingly replacing conventional surgical approaches in several indications, offering targeted treatment, reduced complications, and improved procedural efficiency in dermatology, oncology, cardiology, and aesthetics applications.

Key Market Trends & Insights

• North America dominated the Energy Based Therapeutics Market with the largest revenue share of 38.12% in 2025, supported by advanced healthcare infrastructure, strong adoption of minimally invasive surgical technologies, and high investment in innovative energy-based medical devices across hospitals and specialty clinics.
• The Radiofrequency segment led the market with a 34.27% share in 2025, driven by its widespread use in dermatology, oncology, cardiology, and surgical applications due to high precision, safety, and effectiveness in minimally invasive procedures.
• Asia-Pacific is expected to be the fastest-growing region at a CAGR of 8.3% from 2026 to 2033, fueled by rising healthcare expenditure, increasing prevalence of chronic diseases, expanding hospital infrastructure, and growing adoption of advanced therapeutic technologies across China, India, and Japan.
• The Microwave-based therapeutics segment is expected to be the fastest-growing product type, projected to register a CAGR of 8.0%, owing to increasing use in tumor ablation, pain management, and targeted tissue destruction with minimal damage to surrounding tissues.
• The Surgical segment dominated the market with a 46.18% share in 2025, driven by the widespread use of energy-based devices in minimally invasive surgeries, tumor ablation procedures, tissue dissection, and hemostasis applications
• The Aesthetic application segment is expected to witness the fastest growth at a CAGR of 7.9%, supported by increasing demand for non-invasive cosmetic procedures such as skin tightening, fat reduction, and wrinkle treatment using laser and RF-based technologies.
• Hospitals dominated the end-user segment with a 57.34% market share in 2025, owing to high patient inflow, availability of advanced surgical infrastructure, and strong adoption of energy-based devices for complex medical procedures.
• The Clinics segment is expected to be the fastest-growing end-user category at a CAGR of 8.1%, driven by rising preference for outpatient procedures, cost-effective treatments, and growing penetration of aesthetic and dermatology-focused energy-based systems.

Market Size & Forecast

• Global Market Value (2025): USD 9.21 Billion
• Expected Market Value (2033): USD 17.95 Billion
• Forecast CAGR (2026–2033): 8.70%
• Leading Region in 2025: North America
• Fastest Growing Region: Asia-Pacific

Report Scope and Energy Based Therapeutics Market Segmentation

Energy Based Therapeutics Market Trends

Trend: Growth in Minimally Invasive and Energy-Based Surgical Procedures

Healthcare providers and surgical specialists are increasingly adopting Energy Based Therapeutics to perform minimally invasive procedures with improved precision, reduced patient recovery time, and lower surgical complications. Technologies such as radiofrequency ablation, microwave ablation, ultrasound-based therapy, cryotherapy, and laser/thermal systems are being widely used across oncology, dermatology, gynecology, ophthalmology, and aesthetic medicine. The integration of real-time imaging guidance and robotic-assisted platforms is further enhancing procedural accuracy and expanding clinical applications across hospitals and specialty surgical centers globally.

Energy Based Therapeutics Market Dynamics

Key Market Driver: Rising Prevalence of Chronic Diseases and Growing Demand for Minimally Invasive Treatments

The increasing global burden of chronic diseases such as cancer, cardiovascular disorders, and ophthalmic conditions is a major factor driving demand for Energy Based Therapeutics. These technologies are widely used for tumor ablation, tissue removal, pain management, and cosmetic procedures, offering safer alternatives to open surgeries. Hospitals and ambulatory surgical centers are increasingly shifting toward minimally invasive techniques due to reduced hospital stay, faster recovery, and improved patient outcomes. In addition, rising aging populations and increasing awareness of early disease diagnosis are significantly expanding procedure volumes worldwide. The growing adoption of advanced energy platforms in oncology procedures such as tumor ablation and endoscopic surgeries further strengthens market growth across developed and emerging economies.

Key Restraint/Challenge: High Cost of Advanced Energy-Based Devices and Stringent Regulatory Approval Processes

The primary challenge is the high cost associated with advanced Energy Based Therapeutics systems, including radiofrequency generators, laser platforms, ultrasound devices, and robotic-assisted surgical systems. The substantial capital investment required for procurement, maintenance, and disposable consumables limits adoption among smaller healthcare facilities and cost-sensitive markets. In addition, stringent regulatory approval processes from authorities such as the FDA and CE marking requirements increase time-to-market for new devices, delaying commercialization. The need for extensive clinical validation, safety testing, and physician training further adds to operational complexity and slows down widespread adoption in developing regions.

Key Market Opportunity: Expansion of Robotic-Assisted Surgery and Integration of Smart Energy Platforms

The integration of robotics, artificial intelligence, and real-time imaging with Energy Based Therapeutics is creating significant growth opportunities in the global market. Smart energy devices capable of adaptive tissue recognition, precision energy delivery, and real-time feedback are improving procedural outcomes and reducing complications. The increasing adoption of robotic-assisted surgical systems in hospitals and specialty clinics is further enhancing demand for energy-based instruments. For instance, in recent years, major medical device companies such as Medtronic, Boston Scientific, and Johnson & Johnson have expanded their energy-based surgical portfolios with advanced ablation and soft-tissue treatment systems. In addition, growing investments in outpatient surgical centers and ambulatory care facilities across North America and Asia-Pacific are expected to accelerate the adoption of next-generation Energy Based Therapeutics globally.

Energy Based Therapeutics Market Scope

The Energy Based Therapeutics market is segmented on the basis of product type, clinical application, and end-user.

• By Product Type

On the basis of product type, the Energy Based Therapeutics Market is segmented into microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound systems. The Radiofrequency segment dominated the market with a 34.92% share in 2025, owing to its extensive clinical adoption across minimally invasive surgical procedures, oncology tumor ablation, dermatology, and pain management therapies. It is widely preferred due to its high precision energy delivery, reduced collateral tissue damage, and shorter patient recovery time compared to conventional surgical methods. Hospitals and specialty clinics are increasingly integrating radiofrequency-based systems into advanced surgical workflows, supported by growing adoption of image-guided and robotic-assisted platforms. Rising prevalence of chronic diseases, especially cancer and cardiovascular disorders, is further boosting demand for RF-based therapies. In addition, continuous technological advancements such as multi-electrode RF systems and real-time temperature monitoring are improving procedural outcomes. Strong clinical evidence supporting safety and efficacy is reinforcing physician preference globally. Increasing investments by medical device companies are expanding product availability across developed and emerging markets. Growing use in outpatient surgical centers is also strengthening market penetration. Furthermore, combination therapies integrating RF with imaging systems are gaining traction. Expanding healthcare infrastructure in Asia-Pacific is further accelerating adoption. Overall, radiofrequency remains the most widely used and clinically established energy modality in this market.

The Ultrasound-based therapeutic systems segment is expected to witness the fastest growth at a CAGR of 8.4% from 2026 to 2033, driven by rising demand for non-invasive and precision-based treatment modalities across oncology, neurology, and aesthetic medicine. High-intensity focused ultrasound (HIFU) is gaining strong traction due to its ability to ablate tumors without surgical incisions. Increasing adoption in uterine fibroid treatment, prostate cancer therapy, and cosmetic procedures is significantly expanding clinical applications. The growing preference for outpatient, non-invasive procedures is further accelerating demand. Advancements in real-time imaging integration are improving treatment accuracy and safety. AI-assisted targeting systems are enhancing energy delivery precision and reducing procedure time. Expanding use in physiotherapy and rehabilitation is also contributing to growth. Rising healthcare expenditure in emerging economies is supporting technology adoption. Increasing FDA and CE approvals for advanced ultrasound devices are boosting market confidence. Growing investment in portable and compact ultrasound systems is widening accessibility. Hospitals are increasingly adopting ultrasound-based platforms for multi-specialty applications. Overall, technological innovation and non-invasive treatment demand are driving the fastest growth in this segment.

• By Clinical Application

On the basis of clinical application, the Energy Based Therapeutics Market is segmented into aesthetic, surgical, and ophthalmic applications. The Surgical segment dominated the market with a 46.18% share in 2025, driven by the widespread use of energy-based devices in minimally invasive surgeries, tumor ablation procedures, tissue dissection, and hemostasis applications. Hospitals and surgical centers are increasingly adopting energy-based platforms to improve procedural precision and reduce surgical complications. Growing prevalence of cancer, cardiovascular diseases, and gynecological disorders is significantly increasing surgical procedure volumes globally. The integration of advanced imaging technologies such as MRI, CT, and ultrasound guidance is enhancing surgical accuracy. Robotic-assisted surgical systems are further strengthening adoption in complex procedures. Increasing preference for minimally invasive techniques is reducing hospital stay durations and improving patient outcomes. Strong adoption in oncology surgeries, particularly liver and lung tumor ablation, is reinforcing segment dominance. Expanding healthcare infrastructure and surgical capabilities in emerging economies is further boosting demand. Continuous technological advancements in energy delivery systems are improving safety and efficiency. Rising investments in hospital operating room modernization are supporting adoption. Growing training programs for surgeons are increasing procedural acceptance. Overall, surgical applications remain the backbone of the Energy Based Therapeutics market.

The Aesthetic segment is expected to witness the fastest growth at a CAGR of 8.1% from 2026 to 2033, driven by rising consumer demand for non-invasive cosmetic and dermatological procedures. Increasing popularity of skin tightening, body contouring, hair removal, and fat reduction treatments is fueling adoption. Growing awareness of minimally invasive aesthetic solutions is expanding patient acceptance globally. Rising disposable income and changing beauty standards are boosting procedure volumes. Clinics and medspa centers are rapidly adopting advanced energy-based aesthetic devices. Technological advancements such as fractional RF, laser-based systems, and ultrasound skin tightening are enhancing treatment effectiveness. Short recovery time and minimal downtime are key factors driving patient preference. Increasing influence of social media and cosmetic awareness is further supporting demand. Expanding aesthetic tourism markets in Asia-Pacific and the Middle East are contributing to growth. Rising availability of portable and cost-effective devices is improving accessibility. Regulatory approvals for new aesthetic technologies are accelerating commercialization. Overall, strong lifestyle-driven demand is making aesthetics the fastest-growing clinical segment.

• By End-User

On the basis of end-user, the Energy Based Therapeutics Market is segmented into hospitals, clinics, and others. The Hospitals segment dominated the market with a 52.36% share in 2025, due to their strong infrastructure for performing complex surgical and minimally invasive procedures using advanced energy-based systems. Hospitals are the primary centers for oncology, cardiovascular, and orthopedic surgeries requiring high-precision energy delivery devices. Availability of skilled surgeons, advanced operating rooms, and integrated diagnostic systems further strengthens adoption. Increasing patient inflow for chronic disease treatments is significantly boosting demand. Hospitals are also early adopters of robotic-assisted and image-guided energy platforms. Strong procurement budgets allow deployment of high-cost advanced therapeutic devices. Integration with multidisciplinary care units improves treatment efficiency. Government investments in healthcare infrastructure are further supporting hospital-based adoption. Rising demand for inpatient surgical care continues to reinforce dominance. Expanding use in emergency and trauma care is also contributing to growth. Continuous upgrades in hospital technology infrastructure are enhancing procedural outcomes. Overall, hospitals remain the central hub for energy-based therapeutic procedures globally.

The Clinics segment is expected to witness the fastest growth at a CAGR of 7.9% from 2026 to 2033, driven by the rapid shift toward outpatient and minimally invasive procedures. Increasing demand for cost-effective treatment options is encouraging patients to prefer clinic-based care. Growth of specialty dermatology, ophthalmology, and cosmetic clinics is strongly supporting adoption. Rising prevalence of aesthetic procedures is a major growth driver. Clinics are increasingly investing in compact and portable energy-based devices. Shorter procedure times and faster patient turnover are enhancing operational efficiency. Expanding availability of skilled practitioners in outpatient settings is improving service accessibility. Technological advancements are enabling clinics to offer hospital-level procedures. Growing medical tourism in developing countries is further boosting clinic utilization. Lower infrastructure costs compared to hospitals are accelerating adoption. Increasing insurance coverage for outpatient procedures is also supporting growth. Overall, clinics are emerging as the fastest-growing end-user segment in the market.

Energy Based Therapeutics Market Regional Analysis

North America dominated the Energy Based Therapeutics market and accounted for the largest revenue share of 38.12% in 2025, supported by advanced healthcare infrastructure, strong adoption of minimally invasive surgical technologies, and high investment in innovative energy-based medical devices across hospitals and specialty clinics. The region also benefits from a high prevalence of chronic diseases such as cancer, cardiovascular disorders, and obesity, which is significantly increasing demand for energy-based surgical procedures. Widespread availability of advanced hospital systems, skilled healthcare professionals, and strong reimbursement frameworks is further strengthening market penetration. Increasing adoption of robotic-assisted surgeries, image-guided energy platforms, and AI-integrated surgical systems is enhancing procedural accuracy and patient outcomes. The presence of leading medical device companies and continuous product innovation is accelerating technology advancement.

U.S. Energy Based Therapeutics Market Insight

The U.S. Energy Based Therapeutics market is witnessing strong growth due to rising demand for minimally invasive surgical procedures and advanced energy-based medical technologies across hospitals, ambulatory surgical centers, and specialty clinics. The country’s well-established healthcare system, high healthcare expenditure, and strong adoption of innovative medical devices are driving market expansion. Increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and obesity is significantly boosting procedural volumes. Hospitals are increasingly integrating robotic-assisted surgical systems and AI-powered image-guided energy platforms to improve precision and clinical outcomes. Strong presence of leading medical device companies such as Medtronic, Boston Scientific, Johnson & Johnson, and GE HealthCare is accelerating innovation and product availability. In addition, growing shift toward outpatient surgeries is increasing adoption in ambulatory care centers. Rising FDA approvals for advanced energy-based devices are supporting faster commercialization. Expanding use in aesthetic dermatology and cosmetic procedures is further driving demand. Increasing investments in clinical research and surgical innovation are enhancing treatment capabilities. Strong reimbursement support for minimally invasive procedures is improving patient access. Overall, the U.S. continues to be the largest contributor within North America.

Europe Energy Based Therapeutics Market Insight

The Europe Energy Based Therapeutics market remains a major contributor to global revenue, driven by strong healthcare infrastructure, advanced clinical research capabilities, and high adoption of minimally invasive energy-based surgical technologies. Hospitals and specialty surgical centers across the region are increasingly using radiofrequency, microwave, ultrasound, and cryotherapy systems for oncology, cardiovascular, and ophthalmic treatments. Rising prevalence of chronic diseases and aging population is significantly increasing demand for surgical interventions. Strong regulatory frameworks and healthcare quality standards are supporting safe adoption of advanced medical technologies. Increasing investments in hospital modernization and surgical robotics integration are improving treatment precision and efficiency. Growing preference for outpatient and minimally invasive procedures is reducing hospital stay durations. Continuous advancements in image-guided and AI-assisted surgical platforms are enhancing clinical outcomes. Strong presence of global medical device manufacturers in countries such as Germany, France, and Switzerland is driving innovation. Increasing clinical trials and research collaborations are expanding application areas. Rising focus on digital healthcare transformation is further strengthening adoption. Overall, Europe continues to maintain a strong and stable position in the global market.

U.K. Energy Based Therapeutics Market Insight

The U.K. Energy Based Therapeutics market is experiencing steady growth, supported by rising adoption of minimally invasive surgical technologies and increasing demand for advanced hospital-based treatment solutions. Hospitals and specialty clinics are increasingly integrating energy-based devices for oncology, dermatology, and surgical applications. Growing investments in healthcare infrastructure and surgical innovation are enhancing procedural efficiency. The National Health Service (NHS) is playing a key role in promoting advanced treatment technologies for improved patient outcomes. Increasing use of robotic-assisted surgery and image-guided energy systems is improving clinical precision. Rising prevalence of chronic diseases is further driving procedural demand. Growing adoption of outpatient surgical procedures is reducing healthcare system burden. Increasing focus on patient safety and recovery outcomes is accelerating technology adoption. Strong presence of medical device distributors and research institutions is supporting innovation. Continuous clinical training programs for surgeons are improving adoption rates. Overall, the U.K. remains an important European contributor in this market.

Germany Energy Based Therapeutics Market Insight

The Germany Energy Based Therapeutics market is expanding steadily due to the country’s strong healthcare system, advanced hospital infrastructure, and high adoption of innovative medical technologies. Hospitals and surgical centers are increasingly using energy-based systems for oncology, cardiovascular, and minimally invasive procedures. Rising prevalence of chronic diseases and aging population is significantly increasing demand for surgical interventions. Strong emphasis on medical innovation and engineering excellence is supporting technological advancement in energy-based devices. Increasing integration of robotic-assisted surgical systems and AI-powered imaging technologies is enhancing procedural precision. Germany’s strong regulatory environment ensures high safety and clinical standards. Growing investments in hospital modernization and digital healthcare transformation are improving treatment outcomes. Increasing participation of leading medical device companies and research institutions is accelerating innovation. Expanding use of outpatient surgical procedures is supporting efficiency in healthcare delivery. Rising clinical research and training programs are improving physician adoption. Overall, Germany continues to be a key innovation hub in Europe.

Asia-Pacific Energy Based Therapeutics Market Insight

The Asia-Pacific Energy Based Therapeutics market is expected to witness rapid growth, driven by increasing healthcare expenditure, expanding hospital infrastructure, and rising prevalence of chronic diseases across countries such as China, India, and Japan. Growing awareness of minimally invasive treatment options is significantly boosting adoption of energy-based surgical technologies. Governments across the region are investing heavily in healthcare modernization and expanding access to advanced surgical care. Increasing patient population requiring oncology, cardiovascular, and ophthalmic treatments is driving procedural demand. Hospitals and specialty clinics are rapidly adopting radiofrequency, ultrasound, and thermal ablation systems. Rising medical tourism in countries such as India, Thailand, and South Korea is further supporting market expansion. Increasing availability of cost-effective medical devices is improving accessibility in emerging economies. Growing presence of domestic and global medical device manufacturers is strengthening supply chains. Continuous improvements in healthcare infrastructure are enhancing surgical capabilities. Expanding clinical training programs are improving physician expertise. Increasing digital healthcare adoption is further accelerating growth. Overall, Asia-Pacific is emerging as the fastest-growing regional market.

Japan Energy Based Therapeutics Market Insight

The Japan Energy Based Therapeutics market is witnessing steady growth due to strong healthcare infrastructure, advanced medical technologies, and high adoption of minimally invasive surgical procedures. Hospitals and specialty clinics are increasingly using energy-based systems for oncology, cardiovascular, and ophthalmic treatments. The country’s rapidly aging population is significantly increasing demand for advanced surgical care. Continuous technological innovation in robotics and image-guided surgery is enhancing procedural accuracy. Strong presence of global and domestic medical device companies is supporting product availability and innovation. Increasing adoption of AI-integrated surgical systems is improving clinical outcomes. Government focus on healthcare efficiency and patient safety is driving technology adoption. Rising clinical research activities are supporting innovation in energy-based therapeutics. Expanding outpatient surgical procedures are improving healthcare efficiency. High regulatory standards ensure safety and effectiveness of devices. Increasing investments in hospital digital transformation are enhancing surgical workflows. Overall, Japan remains a highly advanced healthcare market.

China Energy Based Therapeutics Market Insight

The China Energy Based Therapeutics market is growing rapidly, driven by rising healthcare expenditure, expanding hospital infrastructure, and increasing prevalence of chronic diseases. Government initiatives to improve healthcare access and strengthen hospital capabilities are significantly boosting adoption of advanced energy-based surgical systems. Hospitals and specialty clinics are increasingly deploying radiofrequency, microwave, and ultrasound technologies for oncology and minimally invasive procedures. Growing awareness of early diagnosis and treatment is increasing procedural volumes. Expanding medical insurance coverage is improving affordability and patient access. Rapid urbanization and population aging are further driving demand for surgical interventions. Strong domestic manufacturing base is improving availability of cost-effective medical devices. Increasing investments in hospital modernization are enhancing surgical capacity. Rising clinical training programs are improving medical expertise. Growing adoption of AI-assisted and image-guided surgical systems is improving precision. Expanding role of private hospitals is further accelerating adoption. Overall, China is one of the fastest-growing markets in the Asia-Pacific region.

Energy Based Therapeutics Market Share

The Energy Based Therapeutics industry is primarily led by well-established companies, including:

• Johnson & Johnson (U.S.)
• Medtronic plc (Ireland)
• Boston Scientific Corporation (U.S.)
• Abbott Laboratories (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Siemens Healthineers AG (Germany)
• Stryker Corporation (U.S.)
• Olympus Corporation (Japan)
• Hologic, Inc. (U.S.)
• Becton, Dickinson and Company (U.S.)
• B. Braun Melsungen AG (Germany)
• Candela Corporation (U.S.)
• Lumenis Ltd. (Israel)
• Cutera, Inc. (U.S.)
• El.En. S.p.A. (Italy)
• AngioDynamics, Inc. (U.S.)
• Fujifilm Holdings Corporation (Japan)
• Alcon Inc. (Switzerland)
• InMode Ltd. (Israel)
• Alma Lasers (Sisram Medical Ltd.) (Hong Kong)
• Hoya Corporation (Japan)
• Smith & Nephew plc (U.K.)
• Zimmer Biomet Holdings, Inc. (U.S.)
• Bovie Medical Corporation (U.S.)
• Apyx Medical Corporation (U.S.)
• Johnson Matthey (U.K.)
• Terumo Corporation (Japan)
• Cook Medical (U.S.)
• Medline Industries, LP (U.S.)
• GE HealthCare Technologies Inc. (U.S.)
• Karl Storz SE & Co. KG (Germany)
• Richard Wolf GmbH (Germany)
• Erbe Elektromedizin GmbH (Germany)
• ConMed Corporation (U.S.)
• Merz Pharma GmbH & Co. KGaA (Germany)

Latest Developments in Energy Based Therapeutics Market

• In March 2021, Boston Scientific announced the expansion of its radiofrequency ablation portfolio following increased adoption of minimally invasive pain management and cardiac arrhythmia treatment technologies. The company focused on enhancing precision lesion creation systems used in electrophysiology procedures, strengthening its position in energy-based cardiac therapies. This development reflects the broader industry shift toward safer and more controlled energy delivery systems in clinical practice
• In June 2022, Medtronic received expanded regulatory clearances in multiple regions for its advanced microwave and radiofrequency ablation systems used in oncology and cardiology procedures. These approvals supported wider clinical adoption of minimally invasive tumor ablation therapies, particularly for liver, lung, and kidney cancers. The expansion reinforced the growing role of energy-based devices in precision oncology treatment pathways
• In February 2023, Johnson & Johnson (Ethicon) advanced its robotic-assisted energy-based surgical platforms, integrating enhanced energy delivery tools for soft tissue surgery. The update improved surgical precision, reduced blood loss, and enabled better control during minimally invasive procedures. This launch highlighted increasing convergence of robotics and energy-based surgical technologies in operating rooms globally
• In September 2023, Lumenis Ltd. expanded its laser and energy-based aesthetic device portfolio with upgraded platforms for dermatology and ophthalmology applications. The new systems enhanced skin resurfacing, hair removal, and vision correction procedures using improved energy modulation technology. This expansion reflects rising demand for non-invasive aesthetic procedures worldwide
• In April 2024, Abbott Laboratories advanced its electrophysiology and cardiac ablation technologies, strengthening its radiofrequency-based treatment systems used for arrhythmia management. The update included improved catheter-based energy delivery and mapping integration, enabling more accurate cardiac tissue targeting. This development reflects the increasing use of energy-based therapies in cardiovascular disease management
• In August 2024, Boston Scientific introduced next-generation enhancements to its ultrasound and radiofrequency energy platforms used in interventional pain and cardiac procedures. The upgraded systems incorporated real-time feedback mechanisms and improved safety controls, supporting higher procedural accuracy and reduced complications. This aligns with the growing integration of smart monitoring in energy-based therapeutics
• In November 2024, GE HealthCare expanded its AI-enabled imaging and energy-assisted therapeutic guidance systems, enhancing precision in ultrasound-guided procedures. The integration of AI improved lesion targeting and procedural planning in oncology and cardiology applications. This reflects a broader shift toward AI-assisted energy-based clinical workflows
• In March 2025, multiple manufacturers including Medtronic and Stryker expanded production capacity for minimally invasive energy-based surgical devices, driven by rising global demand for non-invasive treatment options. Industry investment in device manufacturing increased significantly between 2022 and 2024, supporting faster commercialization of new energy-based platforms
• In July 2025, the energy-based therapeutics sector witnessed continued FDA clearance activity for radiofrequency, microwave, and ultrasound-based systems across oncology, dermatology, and pain management applications. These approvals strengthened clinical adoption of energy-based therapies across hospitals and ambulatory surgical centers, reinforcing market expansion

SKU-56263